BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4269971)

  • 21. The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.
    Fletcher EA; Redfern PH
    J Pharm Pharmacol; 1970 Dec; 22(12):957-9. PubMed ID: 4395527
    [No Abstract]   [Full Text] [Related]  

  • 22. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC; Toon R; Kleinman J; Heller A
    J Neurochem; 1973 Jan; 20(1):69-80. PubMed ID: 4687208
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons.
    Besson MJ; Cheramy A; Glowinski J
    Eur J Pharmacol; 1969 Jul; 7(1):111-4. PubMed ID: 5821798
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Responses of cortical pyramidal tract cells to amantadine and amphetamine after depletion of central catecholamines.
    Stone TW
    Br J Pharmacol; 1975 Jun; 54(2):244P-245P. PubMed ID: 1148533
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
    Ohashi T; Akita H; Tamura T; Noda K; Honda F
    Arzneimittelforschung; 1972 Jun; 22(6):966-72. PubMed ID: 5068358
    [No Abstract]   [Full Text] [Related]  

  • 27. Transport of dopamine in discrete areas of the striatum and of cerebral cortex in the rat.
    Tassin JP; Blanc G; Stinus L; Berger B; Glowinski J; Thierry AM
    Adv Exp Med Biol; 1976; 69():337-45. PubMed ID: 941742
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1972 Nov; 20(2):156-60. PubMed ID: 4651205
    [No Abstract]   [Full Text] [Related]  

  • 29. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcellular localization of dopamine in the rat striatum.
    Nose T; Segawa T; Takagi H
    Jpn J Pharmacol; 1972 Dec; 22(6):867-9. PubMed ID: 4541492
    [No Abstract]   [Full Text] [Related]  

  • 31. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 32. Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.
    Andén NE; Atack CV; Svensson TH
    J Neural Transm; 1973; 34(2):93-100. PubMed ID: 4722575
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 34. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.
    Glowinski J; Axelrod J; Iversen LL
    J Pharmacol Exp Ther; 1966 Jul; 153(1):30-41. PubMed ID: 4380692
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.
    Scatton B; Cheramy A; Besson MJ; Glowinski J
    Eur J Pharmacol; 1970; 13(1):131-3. PubMed ID: 5496921
    [No Abstract]   [Full Text] [Related]  

  • 36. [Roles of cerebral noradrenaline and dopamine on amphetamine excitation].
    Beauvallet M; Fugazza J; Legrand M
    C R Seances Soc Biol Fil; 1967; 161(11):2161-5. PubMed ID: 4232235
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.
    Andén NE; Stock G
    J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695
    [No Abstract]   [Full Text] [Related]  

  • 38. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.